Markets · 1 sources covering this

KKR-backed Serentica Renewables lands massive $1.19B despite project delays and debt refinancing

Serentica Renewables has secured over $1.19 billion across three financing transactions. This funding will accelerate capacity expansion and support delayed renewable energy projects. A $345 million loan comes from the Asian Development Bank and other lenders. MUFG underwrote a $397 million green term loan now being syndicated. The company aims to supply over 50 billion units of clean energy annually.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Economic TimesLean R·8h ago
KKR-backed Serentica Renewables lands massive $1.19B despite project delays and debt refinancing
Serentica Renewables has secured over $1.19 billion across three financing transactions. This funding will accelerate capacity expansion and support delayed renewable energy projects. A $345 million loan comes from the Asian Development Bank and other lenders. MUFG underwrote a $397 million green term loan now being syndicated. The company aims to supply over 50 billion units of clean energy annually.
Read at Economic Times →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/6716cdb0b9e3e28f7681778d449dbba4b9de5da5"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="KKR-backed Serentica Renewables lands massive $1.19B despite project delays and debt refinancing"></iframe>

KKR-backed Serentica Renewables lands massive $1.19B despite project delays and debt refinancing

How 1 sources are covering this

KKR-backed Serentica Renewables lands massive $1.19B despite project delays and debt refinancing

More from Markets

TVS Motor share price rises 5%, jumps 10% in 2 sessions after Q1 results; is it a stock to buy?

Bajaj Auto share price jumps 4% after auto major posted record revenue and profit in Q1FY27 results: Should you buy?

Lupin, Sun Pharma to Cipla: Pharma stocks decline after Trump’s tariffs plan on generic medicines import

Sensex drops 350 points, Nifty below 24,100 as Middle East conflict escalates. What lies ahead?

Reader

Trust & legal

Across the network